LONDON (Alliance News) - Shares in hVIVO PLC rose on Monday after the scientific research company announced positive results from the study of its flu vaccine.Shares were trading up 25% at Read More
LONDON (Alliance News) - Clinical development and drug discovery business hVIVO PLC said Thursday its loss narrowed in 2017 as Chief Executive Kym Denny stepped aside for Executive Chairman Trevor Read More
LONDON (Alliance News) - hVIVO PLC said on Monday it received encouraging initial results from a Phase IIb study examining FLU-v as a potential universal vaccine against is by Read More
